AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
Claude, GPT, and Gemini Agents Failed Most U.S. Healthcare Workflows in New Benchmark
A new benchmark reported in Carroll County Mirror-Democrat found major failures across leading AI agents when tested on U.S. healthcare workflows. The result is a sharp reminder that general-purpose agents remain far from dependable for complex clinical operations.
Novo Nordisk Uses Custom Azure Agents to Speed Clinical Insight Work
Microsoft says Novo Nordisk is deploying custom AI agents on Azure to accelerate clinical insight generation. The move shows how large pharma is increasingly building internal AI systems to handle research, evidence synthesis, and operational analysis.
Agentic AI Discharge Summaries Show Promise on Safety and Clinician Wellbeing
TechTarget reports that agentic AI discharge summaries may improve safety while easing clinician burden. That combination makes the use case especially attractive because discharge documentation is both high-volume and high-risk. But the work will live or die on how much human review remains in the loop.
Agentic AI Is Forcing Healthcare to Confront a New Kind of Risk
Atos is framing agentic AI as a major opportunity for health and life sciences, but the category raises difficult questions about autonomy, accountability, and control. The more AI systems can act on their own, the more healthcare has to decide where automation should stop.
SPARK’s 5,400-Patient Autonomous Oncology Study Raises the Bar for Trial Biomarker Strategy
SPARK reportedly ran a 5,400-patient oncology study autonomously, a striking example of how agentic AI is entering research operations. The result suggests that trial design, biomarker selection, and analysis workflows may be changing faster than many sponsors have adapted.
Autonomous Pathology Research Suggests Agentic AI Could Reshape Oncology Workflows
Nature reports on agentic AI being used in autonomous pathology research, pointing to a future where models do more than classify images—they help plan and execute parts of the scientific workflow. The work is early, but it hints at a deeper transformation in how oncology research gets done.
Medical AI is entering the regulatory gray zone of agentic systems
A legal discussion of agentic AI in healthcare underscores how quickly the regulatory landscape is moving beyond chatbots and passive decision support. As systems take more autonomous actions, questions of responsibility, oversight, and liability become much harder to avoid.
CCS Deploys Enterprise-Wide Agentic AI for Chronic Care, Signaling a New Phase in Care Management
CCS says it has rolled out enterprise-wide agentic AI for chronic care patients, a sign that AI is moving deeper into care management operations. The move suggests large-scale automation is no longer limited to back-office tasks and is now being tested in patient-facing coordination work.
ImExHS Unveils AI-Native Agentic Platform to Automate Radiology Workflows
ImExHS is positioning its new platform around agentic automation, not just image analysis, reflecting the industry's shift toward workflow orchestration. That framing matters because radiology buyers increasingly want tools that reduce administrative drag, not only tools that label scans.
FDA Turns to AI for Safety Monitoring, Signaling a New Phase in Postmarket Oversight
The FDA’s nationwide adverse event monitoring system is now getting an agentic AI layer, a move that could speed signal detection across devices and drugs. The rollout suggests the agency is increasingly willing to automate parts of its surveillance mission, not just its review workflow.
McKinsey Says Generative AI in Healthcare Is Maturing — and Agentic AI Is the Next Bet
McKinsey’s latest look at healthcare AI suggests the market is moving beyond experimentation into more mature deployment. The next phase, it argues, is agentic AI — systems that can take multi-step actions rather than simply generate text.
Mirxes Shows How Agentic AI Is Moving Into Clinical Support Workflows
Mirxes says it is using Oracle to power agentic AI-enabled clinical support, a sign that healthcare AI is moving beyond passive analytics toward systems that can orchestrate tasks. That is an important step because workflow support often delivers more near-term value than diagnosis. The broader significance is that vendors are now packaging AI as operational infrastructure, not just an algorithmic feature.
AWS Launches Amazon Bio Discovery to Bring Agentic AI to Drug Development
AWS’s Amazon Bio Discovery launch suggests the next phase of life-sciences AI is moving from generic copilots to task-specific agentic systems. The platform is designed to automate parts of research and development, but its long-term value will depend on whether it can reliably fit into regulated scientific workflows.
AWS Moves Deeper Into Drug Discovery With Bio Discovery Agentic AI Platform
AWS’s new Bio Discovery platform underscores how cloud providers are trying to become operating systems for pharmaceutical research. The move could speed discovery work, but it also raises questions about governance, interoperability, and who controls the most valuable research data.
Agentic AI Is Moving Into Radiology Workflow Design, Not Just Image Reading
Diagnostic Imaging argues that agentic AI could unlock efficiency gains in radiology by handling tasks around the reading process. The story reflects a broader industry trend: the value of AI may lie as much in orchestration as in diagnosis.
The Next Healthcare AI Battle Is About Human Oversight, Not Autonomy
AWS is highlighting human-in-the-loop designs for agentic workflows in healthcare and life sciences, underscoring how cautious the sector remains about full automation. The message is clear: AI can assist and accelerate, but humans still need to own the critical decisions.
Hoth’s OpenClaw Launch Shows Smaller Biotechs Want AI Agents, Not Just Models
Hoth Therapeutics has launched its OpenClaw AI platform to accelerate drug discovery, joining a fast-growing wave of companies framing AI as an agentic research co-pilot. The significance is less about Hoth alone and more about how even smaller public biotechs now see proprietary AI workflow tools as part of their strategic identity.
AI Agents Are Challenging Drug Discovery’s Step-by-Step Playbook
A new 36Kr report argues that AI agents are beginning to break from traditional sequential problem-solving in drug development, potentially helping teams overcome cognitive blind spots. The bigger story is that biopharma is testing whether agentic systems can do more than automate tasks and instead reshape scientific reasoning itself.
Amazon Pushes ‘Agentic AI’ Into Provider Workflows, Raising the Stakes for Enterprise Adoption
Amazon’s latest healthcare move brings agentic AI closer to provider operations, signaling that major platform vendors are no longer pitching just copilots but semi-autonomous workflow systems. The shift could accelerate automation in administrative and clinical support tasks, while intensifying scrutiny around oversight, accountability, and integration depth.
Insilico Pitches a New AI Agent Era for Drug Discovery
Insilico Medicine has introduced a new AI agent aimed at accelerating drug discovery workflows, extending the industry’s shift from standalone models toward more autonomous research systems. The move matters less as a product launch in isolation than as another sign that biopharma now wants AI that can coordinate tasks across target identification, design, and decision support.
Insilico’s PandaClaw Pushes Agentic AI Deeper Into Therapeutic Discovery
Insilico Medicine’s PandaClaw launch highlights the next phase of AI drug discovery: agentic systems designed to support biologists directly, not just data scientists. The move suggests the industry is testing whether autonomous or semi-autonomous AI can become a practical layer inside daily discovery work.
NVIDIA GTC Signals That Agentic AI Is Becoming Healthcare and Life Sciences Infrastructure
Coverage from NVIDIA GTC 2026 suggests agentic AI is moving from a conceptual trend to an infrastructure theme across healthcare and life sciences. The shift is significant because it reframes AI from a model-selection exercise into a systems problem involving orchestration, governance, compute, and domain-specific integration.
NVIDIA and Persistent Bet on ‘Agentic AI’ as Pharma Searches for a New Discovery Interface
The NVIDIA-Persistent Systems partnership aims to bring agentic AI into drug discovery, signaling that infrastructure providers see autonomous workflow tools as a major enterprise opportunity in pharma. The announcement reflects a broader race to define the software layer that sits between foundation models and everyday R&D operations.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.